# The National Treatment Agency (Abolition) and the Health and Social Care Act 2012 (Consequential, Transitional and Saving Provisions) Order 2013, Paragraph 66: The Medicines for Human Use (Clinical Trials) Regulations 2004


(1) The Medicines for Human Use (Clinical Trials) Regulations 2004 are amended as follows.
(2) In regulation 2(1) (interpretation), in the definition of “health service body”—
(a) in paragraph (a), omit “Strategic Health Authority,”, and
(b) in paragraph (b), omit “Primary Care Trust,”.
(3) In Schedule 2 (additional provisions relating to ethics committees), in paragraph 3 (membership), after sub-paragraph (5) insert—
“(6) References in sub-paragraph (5) to a health service body include—
(a) a Strategic Health Authority,
(b) a Primary Care Trust,
(c) the National Institute for Health and Care Excellence, and
(d) the Health and Social Care Information Centre.”

---
Source: https://www.legislation.gov.uk/uksi/2013/235/schedule/2/paragraph/66 (the official version)
Page: https://openlegislation.uk/national-treatment-agency-abolition-and-the-health-and-social-care-act-2012-consequential-transitional-and-saving-provisions-order-2013/schedule-2/paragraph-66
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

